A RISK-ADAPTED APPROACH WITH A SHORT-COURSE OF GANCICLOVIR TO PREVENTCYTOMEGALOVIRUS (CMV) PNEUMONIA IN CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION
Ld. Verdonck et al., A RISK-ADAPTED APPROACH WITH A SHORT-COURSE OF GANCICLOVIR TO PREVENTCYTOMEGALOVIRUS (CMV) PNEUMONIA IN CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1686-1686